I thought surely we would hear about the very Big news on EMA implant increase by today. The meeting agenda had it "for adoption" so it does seem likely. The announcement today also showed another growth path with HEP, experts in Italy have treated one case with positive benefits so as they are already doing with some children the physicians may just start prescribing Scenesse since there are no other treatment options? Would only be dozens of patients but that is still a nice little boost. Other growth from Canada, teenage children, organic growth through new treatment centres and new patients, South America etc are also good potential while awaiting blockbuster phase 3 Vitiligo for the really big boost to growth. However the EMA increase would be a really Big and positive step IMO.
All IMO DYOR
CUV Price at posting:
$10.52 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)